TCL Archive In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs January 17, 1992
TCL Archive Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent January 8, 1982
TCL Archive NCI Bypass Budget Request For FY 1982Seeks $1.192 Billion; Would Fund 40% Of Competing R01s May 23, 1980
